Healthcare provider profile · identity verified

J David West, MD

Allopathic & Osteopathic Physicians|Internal Medicine · BATON ROUGE, LA · NPI 1477574002

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show J David West, MD received $37.01 in general payments during 2025 across 2 reported records.

Lilly USA, LLC accounted for 59.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 215 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 115 claims for Mounjaro by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$37.01

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$21.84	59.0%	1	2025
Dexcom, Inc.	Unresolved — no canonical attribution shown	$15.17	41.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$37.01	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$21.84	1	2025
Source payment records 2025-09-18 · Lilly USA, LLC · $21.84 · Open Payments source
Dexcom G6 Transmitter Normalized: dexcom g6 transmitter	Medical Supply	Dexcom, Inc.	$15.17	1	2025
Source payment records 2025-12-02 · Dexcom, Inc. · $15.17 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	215	34
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	115	22

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	1050	241
Levothyroxine Sodium	Levothyroxine Sodium	933	205
Atorvastatin Calcium	Atorvastatin Calcium	688	166
Rosuvastatin Calcium	Rosuvastatin Calcium	634	154
Hydrochlorothiazide	Hydrochlorothiazide	443	102
Metoprolol Succinate	Metoprolol Succinate	437	97
Lisinopril	Lisinopril	417	101
Pantoprazole Sodium	Pantoprazole Sodium	409	99
Metformin Hcl Er	Metformin Hcl	389	92
Omeprazole	Omeprazole	370	83
Simvastatin	Simvastatin	369	93
Gabapentin	Gabapentin	359	101
Trazodone Hcl	Trazodone Hcl	324	80
Potassium Chloride	Potassium Chloride	322	84
Alprazolam	Alprazolam	311	61
Escitalopram Oxalate	Escitalopram Oxalate	269	57
Synthroid	Levothyroxine Sodium	261	48
Losartan Potassium	Losartan Potassium	259	57
Furosemide	Furosemide	254	64
Metformin Hcl	Metformin Hcl	233	64
Meloxicam	Meloxicam	231	61
Zolpidem Tartrate	Zolpidem Tartrate	230	36
Jardiance	Empagliflozin	215	34
Buspirone Hcl	Buspirone Hcl	196	50
Fluticasone Propionate	Fluticasone Propionate	195	70
Duloxetine Hcl	Duloxetine Hcl	184	40
Ezetimibe	Ezetimibe	184	44
Sertraline Hcl	Sertraline Hcl	165	40
Lorazepam	Lorazepam	164	26
Clonazepam	Clonazepam	158	32
Allopurinol	Allopurinol	153	36
Clopidogrel	Clopidogrel Bisulfate	137	33
Olmesartan Medoxomil	Olmesartan Medoxomil	135	33
Citalopram Hbr	Citalopram Hydrobromide	129	28
Metoprolol Tartrate	Metoprolol Tartrate	128	28
Ozempic	Semaglutide	127	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	121	29
Irbesartan	Irbesartan	118	31
Mounjaro	Tirzepatide	115	22
Glimepiride	Glimepiride	113	32
Bupropion Xl	Bupropion Hcl	112	26
Celecoxib	Celecoxib	112	38
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	112	85
Pravastatin Sodium	Pravastatin Sodium	112	34
Valsartan	Valsartan	112	28
Fenofibrate	Fenofibrate	111	28
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	109	31
Tamsulosin Hcl	Tamsulosin Hcl	109	30
Atenolol	Atenolol	108	24
Venlafaxine Hcl Er	Venlafaxine Hcl	100	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	97	76
Tramadol Hcl	Tramadol Hcl	97	33
Fluoxetine Hcl	Fluoxetine Hcl	95	19
Montelukast Sodium	Montelukast Sodium	92	16
Albuterol Sulfate Hfa	Albuterol Sulfate	90	28
Mirtazapine	Mirtazapine	89	13
Nebivolol Hcl	Nebivolol Hcl	89	20
Benazepril Hcl	Benazepril Hcl	87	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	24
Azelastine Hcl	Azelastine Hcl	84	43
Eliquis	Apixaban	84	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	25
Alendronate Sodium	Alendronate Sodium	81	19
Quetiapine Fumarate	Quetiapine Fumarate	81	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	79	66
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	20
Donepezil Hcl	Donepezil Hcl	70	23
Carvedilol	Carvedilol	68	17
Doxazosin Mesylate	Doxazosin Mesylate	68	18
Ondansetron Odt	Ondansetron	65	28
Dropsafe Prep Pads	Alcohol Antiseptic Pads	58	16
Esomeprazole Magnesium	Esomeprazole Magnesium	57	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	57	42
Meclizine Hcl	Meclizine Hcl	56	23
Oxybutynin Chloride Er	Oxybutynin Chloride	56	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	54	18
Fenofibrate	Fenofibrate Nanocrystallized	52	suppressed
Januvia	Sitagliptin Phosphate	52	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	50	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	50	12
Hydralazine Hcl	Hydralazine Hcl	48	18
Prednisone	Prednisone	48	40
Linzess	Linaclotide	47	suppressed
Valacyclovir	Valacyclovir Hcl	47	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	46	13
Famotidine	Famotidine	45	13
Methocarbamol	Methocarbamol	45	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	35
Promethazine Hcl	Promethazine Hcl	43	suppressed
Lovastatin	Lovastatin	42	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Warfarin Sodium	Warfarin Sodium	41	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Memantine Hcl	Memantine Hcl	40	11
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Colchicine	Colchicine	36	15
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Megestrol Acetate	Megestrol Acetate	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Cephalexin	Cephalexin	32	15
Methylprednisolone	Methylprednisolone	32	28
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Glipizide	Glipizide	30	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Vascepa	Icosapent Ethyl	29	suppressed
Levofloxacin	Levofloxacin	28	23
Pregabalin	Pregabalin	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Baclofen	Baclofen	27	12
Diazepam	Diazepam	27	11
Estradiol	Estradiol	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Niacin Er	Niacin	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Mupirocin	Mupirocin	25	22
Nexletol	Bempedoic Acid	25	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Kerendia	Finerenone	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Temazepam	Temazepam	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Finasteride	Finasteride	22	suppressed
Ibandronate Sodium	Ibandronate Sodium	22	suppressed
Rizatriptan	Rizatriptan Benzoate	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Acebutolol Hcl	Acebutolol Hcl	21	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	11
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Premarin	Estrogens, Conjugated	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Nabumetone	Nabumetone	20	13
Azithromycin	Azithromycin	19	18
Digoxin	Digoxin	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Fluconazole	Fluconazole	17	14
Imipramine Hcl	Imipramine Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Jentadueto	Linagliptin/Metformin Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Scopolamine	Scopolamine	15	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Febuxostat	Febuxostat	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	13	suppressed
Naproxen	Naproxen	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Indapamide	Indapamide	11	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$37.01 · 2 records	Lilly USA, LLC	Dexcom G6 Transmitter, ZEPBOUND	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error